Provider review
MaxLife review
Names its compounding pharmacy, and prices the two molecules twenty dollars apart.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$100/mo sema · $120/mo tirz
Visit MaxLifeProvenance is the part of a compounded purchase a reader can least easily check, and it is stated here rather than implied.
Price as published
MaxLife
$100/mo sema · $120/mo tirz
FDA warning letter · MaxLife · February 2026 · addressed to MaxLife Technologies Inc. dba Maxlife. Details in our review.
- Vs median
- $75/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by Hallandale Pharmacy
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Two figures, one per molecule, both low, both visible without an intake, and a compounding pharmacy named on the page. That combination is rarer than it sounds. The naming matters more than a reader might assume: provenance is part of what you are buying with a compounded drug, and the difference between a seller that names its pharmacy and one that says only "licensed partners" is the difference between a claim you can check and one you cannot. The company is also unusually candid about what it is, describing itself as a platform that arranges access to care rather than as the manufacturer or the pharmacy. The narrow gap between the two molecules is the other thing to notice. Twenty dollars between them is much tighter than this category usually manages, and it means the choice can be made on clinical grounds rather than on price, which is how it ought to be made. What is missing is the same thing missing almost everywhere: no milligram sits behind either number. For a reader intending to hold a deliberately small dose that is the whole question, because a figure with no quantity attached cannot be tested against the amount of drug actually dispensed, and there is nothing to say whether the price moves as the dose climbs. The asterisk on the semaglutide page points at a condition the page itself does not spell out.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to know which pharmacy compounds what you inject before you order it
- You are choosing between the two molecules and would rather not have price decide it
- You want a low figure per molecule that is readable without completing an intake
Look elsewhere if
- You need to match a price to a milligram. Neither figure carries a dose
- You want to know what happens to the bill as you titrate upward. Nothing says
- You want the condition behind the asterisk resolved before you commit
What it actually costs
Price as published
$100/mo sema · $120/mo tirz
- Vs median
- $75/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. The compounding pharmacy is named rather than described as "a licensed partner", which is uncommon here and covers the part of a compounded purchase you can least easily check yourself. Both molecules carry their own price, and the gap between them is narrow enough that you can choose on clinical grounds rather than cost. No low-dose product is offered, no dose sits behind either price, and nothing says whether either figure holds as the dose climbs, so if you plan to hold a small amount you cannot tell how much of the charge buys drug you will not use.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- The compounding pharmacy is named rather than described only as a licensed partner.
- Both molecules are priced separately and both figures are low for compounded weekly shots.
- The gap between the two is small enough that the choice can be made clinically.
Pharmacy, labs and oversight
MaxLife names its pharmacy: Hallandale Pharmacy. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What MaxLife publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNames its pharmacy: Hallandale Pharmacy.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to MaxLife in February 2026. It is addressed to MaxLife Technologies Inc. dba Maxlife — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how MaxLife is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
Two figures, one per molecule, both low, both visible without an intake, and a compounding pharmacy named on the page. That combination is rarer than it sounds. The naming matters more than a reader might assume: provenance is part of what you are buying with a compounded drug, and the difference between a seller that names its pharmacy and one that says "licensed U.S. partners" is the difference between a claim you can check and one you cannot. MaxLife is also unusually candid about what it is, describing itself as a platform that arranges access to care rather than as the manufacturer or the pharmacy. The narrow gap between the two molecules is the other thing to notice. Twenty dollars between semaglutide and tirzepatide is much tighter than this category usually manages, and it means the choice between them can be made on clinical grounds rather than on price, which is how it ought to be made. What is missing is the same thing missing almost everywhere: no milligram sits behind either number. For a reader intending to hold a deliberately small dose that is the whole question, because a figure with no quantity attached cannot be tested against the amount of drug actually dispensed, and there is no indication whether the price moves as the dose climbs. The asterisk on the semaglutide page points at a condition the rendered page does not spell out.
The honest cons
No dose sits behind either figure, so neither can be matched to an amount of drug.
- Nothing says whether either price holds as the dose is increased.
- The semaglutide figure carries an asterisk whose condition is not spelled out.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
MaxLife is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way MaxLife does. Both are partners: we may earn a commission if you start care through these links.
Partner
Strut Health
$99/mo sema lozenge (auto-refill)
Standard plan, self-directed low dose
FDA warning letter · Strut Health · February 2026 · addressed to Strut Health, LLC dba Strut. Details in our review.
Partner
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
Standard plan, self-directed low dose
Where this sits
#232 of 548
Ordered with the companies that pay us first, and MaxLife is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Is compounded GLP-1 safe?
- Microdosing semaglutide
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Direct Meds
From $249/mo sublingual · $297/mo injection
FDA warning letter · Direct Meds · September 2025 · addressed to directmeds.com, Inc. dba DirectMeds. Details in our review.
- Vs median
- $74/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by CraftedRx · ChemistryRx
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Direct Meds review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.